Healthcare -
Biotechnology - NASDAQ - US
$ 8.975
4.36 %
$ 399 M
Market Cap
-5.19
P/E
CADL - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss CADL - Candel Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR